Results 171 to 180 of about 89,075 (280)

Five Cases of Hepatic Mesenchymal Tumors Diagnosed by Endoscopic Ultrasound‐Guided Tissue Acquisition

DEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Percutaneous biopsy remains the gold standard for diagnosing focal liver lesions; however, endoscopic ultrasound‐guided tissue acquisition (EUS‐TA) has recently emerged as a promising alternative. Although its diagnostic performance is favorable, most available evidence has focused on epithelial tumors, and reports on mesenchymal tumors are ...
Yuichi Takano, Naoki Tamai, Jun Noda, Tetsushi Azami, Fumitaka Niiya, Tatsuya Yamagami, Akihiro Nakamura, Genshu Tate, Takafumi Ogawa, Masatsugu Nagahama   +9 more
wiley   +1 more source

Simultaneous Placement of Three Thin‐Delivery Multi‐Hole Self‐Expandable Metallic Stents for Malignant Hilar Biliary Obstruction Using a Large‐Channel Duodenoscope

DEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Endoscopic biliary drainage for malignant hilar biliary obstruction is technically demanding especially when multiple ducts require drainage. Plastic inside stents are widely used because of their removability and ease of exchange, but multiple insertion is often hindered by stent interference.
Akinobu Koiwai, Morihisa Hirota, Tomohiro Oikawa, Kei Ishikawa, Chihiro Yunomura, Takuro Nakaya, Takehito Itoh, Yuki Miyashita, Nana Inomata, Kennichi Satoh   +9 more
wiley   +1 more source

Prognostic value of preoperative serum ferritin in cholangiocarcinoma patients. [PDF]

Sci Rep
Chen L, Hu S, Liu L, He S, Fan H, Shao F, Li L, Zhang X.   +7 more
europepmc   +1 more source

Functional Difference of MYC and MYCN in Combined Hepatocellular-Cholangiocarcinoma: Regulation of Differentiation by HNF1B. [PDF]

Cancer Sci
Combined hepatocellular–cholangiocarcinoma (cHCC‐CCA) is a tumor consisting of a mixture of hepatocellular carcinoma and intrahepatic cholangiocarcinoma (CCA) components, but the mechanisms of development are poorly understood. The activation of Myc may be implicated in the formation of cHCC‐CCA and this work demonstrates for the first time that Myc ...
Goto M, Yamamoto M, Tanaka H, Fujii Y, Takasawa K, Kamikokura Y, Kamikokura M, Kobayashi N, Murakami T, Nishikawa Y, Takasawa A.   +10 more
europepmc   +2 more sources

Pre‐diagnostic immunological markers of bacterial translocation and liver cancer risk: A nested case–control analysis of 12 prospective cohorts

International Journal of Cancer, Volume 158, Issue 7, Page 1801-1812, 1 April 2026.
What's new? Disruption of the gut–liver axis has been suggested to play an important role in liver carcinogenesis. However, limited prospective research has explored associations between potentially harmful gut‐derived bacterial products and liver cancer risk.
Cody Z. Watling, Peter T. Campbell, Barry I. Graubard, Yanyu Wang, Andrew T. Gewirtz, Xuehong Zhang, Matthew J. Barnett, Julie E. Buring, Yu Chen, A. Heather Eliassen, J. Michael Gaziano, Jonathan N. Hofmann, Wen‐Yi Huang, Jae H. Kang, Jill Koshiol, Erikka Loftfield, I‐Min Lee, Steven C. Moore, Lorelei A. Mucci, Marian L. Neuhouser, Christina C. Newton, Mark P. Purdue, Howard D. Sesso, Martha Shrubsole, Rashmi Sinha, Lesley Tinker, Matthew Triplette, Caroline Y. Um, Kala Visvanathan, Eleanor L. Watts, Jean Wactawski‐Wende, Walter Willett, Fen Wu, Wei Zheng, Dinesh Barupal, Jessica L. Petrick, Katherine A. McGlynn   +36 more
wiley   +1 more source

The clinical pathological significance of ILK and FABP4 protein expression in EHCC. [PDF]

Medicine (Baltimore)
Yu J, Tan XG, Zhou F, Xiao MZ, Feng W.
europepmc   +1 more source

Increased incidence, survival, and registration quality of primary hepato‐pancreato‐biliary cancers in the Netherlands Cancer Registry

International Journal of Cancer, Volume 158, Issue 5, Page 1237-1249, 1 March 2026.
What's New? Primary hepato‐pancreato‐biliary cancers have poor prognosis and their reporting often scores low on standard data quality indicators in population‐based cancer registries. This comprehensive evaluation of cases in the Netherlands Cancer Registry shows that both the incidence and survival rates of most primary hepato‐pancreato‐biliary ...
Lydia G. van der Geest, Marianne van der Mark, Joanne Verheij, Arantza Farina Sarasqueta, Judith de Vos‐Geelen, Marc G. Besselink, Vincent E. de Meijer, Ignace H. J. T. de Hingh, Bert A. Bonsing, Philip R. de Reuver, Francois E. J. A. Willemssen, Pauline A. J. Vissers, Otto Visser, the Dutch Pancreatic Cancer Group and the Dutch Hepatocellular & Cholangiocarcinoma Group   +13 more
wiley   +1 more source

MUC1 as a biomarker in primary sclerosing cholangitis and cholangiocarcinoma. [PDF]

Ann Gastroenterol
Hashash JG, Beatty P, Yan IK, Nakhleh R, Camilleri M, Harnois D, Farraye FA, Francis FF.   +7 more
europepmc   +1 more source

International Contrast Ultrasound Society Safety Round Table

Journal of Ultrasound in Medicine, Volume 45, Issue 3, Page 473-485, March 2026.
The international Contract Ultrasound Society (ICUS) held a round table discussion on the safety of ultrasound contrast agents for cardiology, radiology, and pediatrics on September 4, 2024. The panel included international experts on ultrasound contrast.
Richard G. Barr, Jordan Strom, Dirk A. Clevert, Stephanie R Wilson, Thomas Porter, Kassa Darge   +5 more
wiley   +1 more source

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.

Journal of Clinical Oncology, 2017
M. Javle, M. Lowery, R. Shroff, K. Weiss, C. Springfeld, M. Borad, R. Ramanathan, L. Goyal, S. Sadeghi, T. Macarulla, A. El-Khoueiry, R. Kelley, I. Borbath, S. Choo, D. Oh, P. Philip, Li‐Tzong Chen, T. Reungwetwattana, E. Van Cutsem, K. Yeh, K. Ciombor, R. Finn, Anuradha Patel, S. Sen, D. Porter, R. Isaacs, A. Zhu, G. Abou-Alfa, T. Bekaii-Saab   +28 more
semanticscholar   +1 more source